TG4010

MVA-MUC1-IL-2 therapeutic cancer vaccine · Transgene

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TG4010, covering 2014-07-16 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: TG4010 and Nivolumab in Patients With Lung Cancer [Phase 2]